State Street Corp Enochian Biosciences Inc Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Enochian Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 1,275,718 shares of ENOB stock, worth $5.87 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,275,718
Previous 97,687
1205.92%
Holding current value
$5.87 Million
Previous $449,000
1206.9%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ENOB
# of Institutions
42Shares Held
14MCall Options Held
33.7KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA5.64MShares$26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.73MShares$7.95 Million0.0% of portfolio
-
Morgan Stanley New York, NY454KShares$2.09 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL303KShares$1.4 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...